Moreover, by targeting PPAR-δ, Seladelpar may exert additional beneficial effects on lipid metabolism, insulin sensitivity, and inflammatory pathways, which are dysregulated in PBC and contribute to disease pathogenesis. This evidence concerns the gene PPARD and primary biliary cholangitis.